Axiobionics plans Ann Arbor move, to create 100 new jobs

Ann Arbor took another one from Columbus, and this doesn’t have anything to do with sports. Axiobionics has called Columbus home for 15 years, but it’s packing up and heading to the land of Maize and Blue before the summer is over. The life sciences company, formerly BioFlex, is bringing its dozen or so jobs and plans to hire another 100 here within the next five years. The firm had looked at sites across the nation, but choose Ann Arbor after receiving a $1.4 million state tax credit over seven years. Locations Axiobionics considered included Arizona and Texas. The company also liked Ann Arbor’s established software community and access to a top-notch teaching hospital like the University of Michigan Hospital.”This is just a good environment for therapy and rehab,” says Joel Dalton, vice president of Axiobionics. “That’s something that Ohio lacks.”Axiobionics develops and markets medical devices for pain control and neuro rehabilitation in patients with severe spinal cord and brain injuries. This therapy system uses customized electrical stimulation devices designed to improve stability, build muscles and increase circulation in prosthetic patients. Axiobionics plans to invest $2.89 million as part of its relocation. Some of those new hires that comes with that investment will be made in the near future.Source: Joel Dalton, vice president of AxiobionicsWriter: Jon Zemke

Getting your Trinity Audio player ready...

Ann Arbor took another one from Columbus, and this doesn’t have anything to do with sports.

Axiobionics has called Columbus home for 15 years, but it’s packing up and heading to the land of Maize and Blue before the summer is over. The life sciences company, formerly BioFlex, is bringing its dozen or so jobs and plans to hire another 100 here within the next five years.

The firm had looked at sites across the nation, but choose Ann Arbor after receiving a $1.4 million state tax credit over seven years. Locations Axiobionics considered included Arizona and Texas. The company also liked Ann Arbor’s established software community and access to a top-notch teaching hospital like the University of Michigan Hospital.

“This is just a good environment for therapy and rehab,” says Joel Dalton, vice president of Axiobionics. “That’s something that Ohio lacks.”

Axiobionics develops and markets medical devices for pain control and neuro rehabilitation in patients with severe spinal cord and brain injuries. This therapy system uses customized electrical stimulation devices designed to improve stability, build muscles and increase circulation in prosthetic patients.

Axiobionics plans to invest $2.89 million as part of its relocation. Some of those new hires that comes with that investment will be made in the near future.

Source: Joel Dalton, vice president of Axiobionics
Writer: Jon Zemke

Author

Our Partners

30044
30045
30046
30047
30049
Washtenaw ISD logo
Eastern Michigan University
Ann Arbor Art Center
UMS
U of M Arts Initiative
Engage EMU

Common Ground Is Brewing

Support local stories and receive our signature roast straight to your door when you join at the Standard level (or above).

Drink Better, Read Local

Close the CTA

Don't miss out!

Everything Ann Arbor and Ypsilanti, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.